PONTECORVO, SIMONA
 Distribuzione geografica
Continente #
NA - Nord America 1.344
EU - Europa 429
AS - Asia 276
SA - Sud America 5
AF - Africa 3
Totale 2.057
Nazione #
US - Stati Uniti d'America 1.330
IT - Italia 165
SG - Singapore 112
SE - Svezia 109
IN - India 82
CN - Cina 60
DE - Germania 48
FI - Finlandia 33
UA - Ucraina 14
RO - Romania 13
CA - Canada 12
ID - Indonesia 10
BG - Bulgaria 9
GB - Regno Unito 7
HK - Hong Kong 6
NL - Olanda 6
AR - Argentina 5
IE - Irlanda 5
RU - Federazione Russa 5
FR - Francia 4
BE - Belgio 3
TG - Togo 3
MK - Macedonia 2
MX - Messico 2
AL - Albania 1
AM - Armenia 1
CH - Svizzera 1
CZ - Repubblica Ceca 1
ES - Italia 1
IL - Israele 1
KH - Cambogia 1
LU - Lussemburgo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TR - Turchia 1
UZ - Uzbekistan 1
Totale 2.057
Città #
Fairfield 225
Ashburn 123
Chandler 108
Woodbridge 91
Singapore 88
Houston 82
Rome 76
Cambridge 68
Seattle 64
Wilmington 60
Dearborn 53
Ann Arbor 37
Princeton 33
Plano 30
Santa Clara 30
Beijing 26
Lawrence 24
San Paolo di Civitate 23
Millbury 15
Boston 14
Munich 14
Norwalk 14
San Diego 14
Helsinki 11
Jakarta 10
Sofia 9
Andover 8
Fremont 7
Ottawa 7
Phoenix 7
Des Moines 6
Hong Kong 6
San Mateo 6
Dublin 5
Federal 5
Hefei 5
Milan 5
Moscow 5
New York 5
Toronto 5
Venezia 5
Fasano 4
Kunming 4
Amsterdam 3
Atlanta 3
Brussels 3
Bühl 3
Jacksonville 3
Lomé 3
Bad Bellingen 2
Bari 2
Buffalo 2
Dallas 2
Genzano 2
Guangzhou 2
Hyderabad 2
Jinan 2
Laurel 2
Los Angeles 2
Mannheim 2
Nanchang 2
Nanjing 2
Padova 2
Paris 2
Perugia 2
Pisa 2
San Jose 2
Santa Maria La Carita 2
Skopje 2
Terni 2
Trumbull 2
Bangkok 1
Bern 1
Bonndorf 1
Bratislava 1
Bremen 1
Brno 1
Chengdu 1
Chicago 1
Chongqing 1
Colleferro 1
Falkenstein 1
Falls Church 1
Frankfurt am Main 1
Fuzhou 1
Genzano di Roma 1
Grafing 1
Gunzenhausen 1
Haikou 1
Leawood 1
Lissone 1
Luxembourg 1
Madrid 1
Nanning 1
Nürnberg 1
Phnom Penh 1
Pomezia 1
Redmond 1
Riva 1
Saint Louis 1
Totale 1.528
Nome #
Attention-related changes in short-term cortical plasticity help to explain fatigue in multiple sclerosis 111
Reactivation of hepatitis B virus with immune-escape mutations after ocrelizumab treatment for multiple sclerosis 96
Dynamic changes of mmp-9 plasma levels correlate with jvc reactivation and immune activation in natalizumab-treated multiple sclerosis patients 94
Human polyomavirus JC replication and non coding control region analysis in multiple sclerosis patients under natalizumab treatment 89
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by immune-mediated diseases under treatment with biologics: an observational study. 87
Exit strategies for "needle fatigue" in multiple sclerosis: a propensity score-matched comparison study 84
From high- to low-frequency administered interferon-beta for multiple sclerosis: A multicenter study 82
Abortion induces reactivation of inflammation in relapsing-remitting multiple sclerosis 82
Peripheral blood biomarkers in multiple sclerosis. 82
Real-world effectiveness of natalizumab and fingolimod compared with self-injectable drugs in non-responders and in treatment-naïve patients with multiple sclerosis 79
Natalizumab affects T-cell phenotype in multiple sclerosis: implications for JCV reactivation 79
Ultrasonographic evaluation of cerebral arterial and venous haemodynamics in multiple sclerosis: a case-control study. 79
MR venography in patients with multiple sclerosis and correlation with clinical and MRI parameters 78
Autoantibodies to the adenosine triphosphate synthase play a pathogenetic role in Alzheimer's disease 78
Fingolimod vs dimethyl fumarate in multiple sclerosis. a real-world propensity score-matched study 75
H-magnetic resonance spectroscopy. diagnostic tool in recurrent headache in systemic lupus erythematosus. a case report 70
Dimethyl fumarate in the management of multiple sclerosis: Appropriate patient selection and special considerations 68
Modificazioni immunofenotipiche dei linfociti T in pazienti affetti da sclerosi multipla in trattamento con natalizumab: implicazioni per la riattivazione del JC virus 66
Impaired cortical deactivation during hand movement in the relapsing phase of multiple sclerosis: a cross-sectional and longitudinal fMRI study 65
JC virus-DNA detection is associated with CD8 fffector accumulation in peripheral blood of patients with multiple sclerosis under natalizumab treatment, independently from JC virus serostatus 65
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 64
CD49d expression on T lymphocytes and CD8 effector percentage as predictors of JC virus reactivation in multiple sclerosis patients on natalizumab treatment. 57
null 57
null 56
null 49
Human Polyomavirus JC monitoring and CD49d expression in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study. 46
Human Polyomavirus JC monitoring in dynamic cohorts of multiple sclerosis patients treated with natalizumab: an observational study 42
Human Polyomavirus JC monitoring and noncoding control region analysis in dynamic cohorts of individuals affected by multiple sclerosis under treatment with natalizumab: an observational study 39
Neurological Involvement in Primary Sjogren Syndrome: A Focus on Central Nervous System 37
Chronic Cerebro-Spinal Venous Insufficiency is not significantly associated to Relapsing-Remitting Multiple Sclerosis. 35
Cognitive fatigue in multiple sclerosis: an fMRI study 23
Olanzapine-induced neutropenia in a patient with systemic lupus erythematosus: a role of Fc gamma RIIIb polymorphism? 23
Somatosensory temporal discrimination threshold is impaired in patients with multiple sclerosis 20
Intradetrusorial botulinum toxin in patients with multiple sclerosis: A neurophysiological study 13
Totale 2.170
Categoria #
all - tutte 5.990
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.990


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020279 0 0 0 0 0 0 90 56 52 47 21 13
2020/2021130 17 15 8 3 2 10 8 5 23 23 15 1
2021/2022371 2 19 36 21 45 19 2 33 22 23 91 58
2022/2023382 74 86 34 30 40 33 12 14 26 6 15 12
2023/2024163 10 15 1 19 11 21 5 23 0 29 14 15
2024/2025202 9 54 19 22 60 36 2 0 0 0 0 0
Totale 2.170